BOCHK Asset Management’s Pfizer PFE Stock Holding History

BOCHK Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$72.2K	Sell	3,000 -132,800	-98%	-$3.47M	0.01%	114
2026 Q1	$3.81M	Buy	135,800 +96,600	+246%	+$2.57M	0.79%	38
2025 Q4	$976K	Buy	39,200 +37,900	+2,915%	+$956K	0.26%	34
2025 Q3	$33.1K	Buy	+1,300	New	+$32.1K	0.01%	77

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BOCHK Asset Management's PFE Position: Q2 2026 in Review

BOCHK Asset Management reduced its Pfizer (PFE) stake by 98% in Q2 2026, selling an estimated $3.47M and leaving 3,000 shares worth $72.2K. The position accounts for 0.01% of the portfolio, ranked #114.

BOCHK Asset Management first reported a position in PFE in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.81M in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

BOCHK Asset Management held 3,000 shares of Pfizer worth $72.2K as of Q2 2026.
BOCHK Asset Management sold 132,800 Pfizer shares in Q2 2026, an estimated $3.47M.
Pfizer made up 0.01% of BOCHK Asset Management's portfolio in Q2 2026, its #114 holding.
BOCHK Asset Management first reported a position in Pfizer in Q3 2025 and has held it in 4 quarters since.
BOCHK Asset Management's Pfizer position peaked at $3.81M in Q1 2026.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on BOCHK Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.